News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mayer Arie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Bought 5,009 shares
@ $2.22, valued at
$11.1k
Bought 3,800 shares
@ $2.21, valued at
$8.4k
|
|
| 08/01/2022 |
4
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 05/10/2022 |
4/A
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 6,000 shares
@ $0 |
|
| 05/10/2022 |
4
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 3,000 shares
@ $25.6, valued at
$76.8k
|
|
| 01/05/2022 |
4
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 6,000 shares
@ $0
Granted 10,000 options to buy
@ $13.89, valued at
$138.9k
|
|
| 01/14/2020 |
4
| Mayer Arie (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 20,000 options to buy
@ $4.8, valued at
$96k
|
|
| 12/11/2019 |
3
| Mayer Arie (Director) has filed a Form 3 on ORAMED PHARMACEUTICALS INC. |
|
|